After some setbacks, financial loses, bad investments, and market drop, the Cryer Pharmaceuticals board decided to sell almost every shares to a private group from Kusari.
Althought being a Liberty company, with every right that comes with that, a libertonian forefront CEO and board, the company now has Kusari influence, from a group of investors who want to maintain its anonymity for now.
Profit is the main goal here. The credits injection to the company boosted its operations. New researches within its instalations, new drugs, new markets, and some undercover operations to regain the market. Rumors abound that with this new financial boost Cryer is financing a number of expeditions to the border worlds in search of genetic material from alien flora and fauna that may provide the ultimate solution. While it holds several significant patents, Cryer has not perfected its ultimate product: an anti-aging drug based on Cardamine.
Cryer~will be working as a main branch of Cryer. Being under some shadow influence their projects on R&D will be secret, pitiless and macabre to the general population, to reach its goals.
History:
312 A.S. - Max Cryer invents Synthetic Marijuana.
330 A.S. - Max Cryer founds Cryer Pharmaceuticals.
332 A.S. - Denver Research Institute opens on Planet Denver.
642 A.S. - Cryer Research Station in Cambridge is opened. Joint project with Cambridge Research Institute.
727 A.S. - The Atka Research Station is opened.
820 A.S. - Cryer share holders sells almost every percentage to a private group from Kusari.
Bases Owned:
Atka Research Station, Sigma-17
Cambridge Research Station, Cambridge
![[Image: CryerLogo.png]](http://discoverygc.com/wiki/images/9/91/CryerLogo.png)
![[Image: image.jpg]](http://s8.postimg.org/nvwo3ecth/image.jpg)
